BIOORGANIC & MEDICINAL CHEMISTRY LETTERS-玩家互动社区-Sensace新潮游戏活动网

2026-02-26 03:46:22 玩家互动社区

首页期刊介绍

SCI

Scopus

国外一般学术期刊

成功案例服务流程合规与保密SCI快速录用商务合作SCI论文润色

期刊检索

精准选刊

期刊推荐

期刊资讯

关于我们进入杂志社预审系统个人中心首页>>BIOORGANIC & MEDICINAL CHEMISTRY LETTERSBIOORG MED CHEM LETT影响因子：2.2JCR分区：Q3中科院分区：医学 4区是否综述期刊：否是否预警：不在预警名单内是否OA：否出版国家/地区：ENGLAND出版社：Elsevier Ltd发刊时间：1991收录数据库：SCIE/Scopus收录ISSN：0960-894X期刊介绍Bioorganic & Medicinal Chemistry Letters presents preliminary experimental or theoretical research results of outstanding significance and timeliness on all aspects of science at the interface of chemistry and biology and on major advances in drug design and development. The journal publishes articles in the form of communications reporting experimental or theoretical results of special interest, and strives to provide maximum dissemination to a large, international audience.《生物有机与药物化学快报》介绍了在化学和生物学的界面上的科学的各个方面以及药物设计和开发的主要进展方面具有突出意义和及时性的初步实验或理论研究结果。该杂志以通讯的形式发表文章，报告特别感兴趣的实验或理论结果，并努力向大量的国际读者提供最大限度的传播。相关文章毕业论文和期刊论文有什么区别？详解Thesis与Article的本质差异2026-01-04BIOORGANIC & MEDICINAL CHEMISTRY LETTERS药物与有机化学领域期刊，审稿周期适中！2025-08-03Bioorganic & Medicinal Chemistry Letters审稿周期2024-02-07Bioorganic & Medicinal Chemistry Letters容易中吗2024-01-09Bioorganic & Medicinal Chemistry Letters投稿经验分享2023-11-20BIOORGANIC & MEDICINAL CHEMISTRY LETTERS投稿完整指南2023-11-16BIOORGANIC & MEDICINAL CHEMISTRY LETTERS好投吗2023-11-12Bioorganic & Medicinal Chemistry Letters的分区2023-11-11BIOORGANIC & MEDICINAL CHEMISTRY LETTERS怎么样2023-09-09BIOORGANIC & MEDICINAL CHEMISTRY LETTERS难投吗？2023-08-20 年发文量 307 国人发稿量 99.13 国人发文占比 0.32% 自引率 - 平均录取率0

数据非官方，来自网友分享经验

平均审稿周期平均2.0个月平均7周

数据非官方，来自网友分享经验

版面费 US$3550 偏重研究方向医学-医药化学期刊官网 http://www.elsevier.com/wps/find/journaldescription.cws_home/972/description#description 投稿链接 https://www.editorialmanager.com/BMCL期刊高被引文献Cyclin dependent kinase (CDK) inhibitors as anticancer drugs: Recent advances (2015-2019).来源期刊：Bioorganic & medicinal chemistry lettersDOI：10.1016/j.bmcl.2019.126637Quercetin-3-oleoyl derivatives as new GPR40 agonists: Molecular docking studies and functional evaluation.来源期刊：Bioorganic & medicinal chemistry lettersDOI：10.1016/j.bmcl.2019.05.018Dual inhibition of Kif15 by oxindole and quinazolinedione chemical probes.来源期刊：Bioorganic & medicinal chemistry lettersDOI：10.1016/j.bmcl.2018.12.008Design, synthesis, and biological evaluation of novel pyrrolo[1,2-a]pyrazine derivatives.来源期刊：Bioorganic & medicinal chemistry lettersDOI：10.1016/j.bmcl.2019.03.044Synthesis and evaluation of a novel quinoline-triazole analogs for antitubercular properties via molecular hybridization approach.来源期刊：Bioorganic & medicinal chemistry lettersDOI：10.1016/j.bmcl.2019.126671Design, synthesis, evaluation and molecular modeling study of 4-N-phenylaminoquinolines for Alzheimer disease treatment.来源期刊：Bioorganic & medicinal chemistry lettersDOI：10.1016/j.bmcl.2019.03.050Triazolopyrimidine and triazolopyridine scaffolds as TDP2 inhibitors.来源期刊：Bioorganic & medicinal chemistry lettersDOI：10.1016/j.bmcl.2018.11.044Discovery of novel 2,3-dihydro-1H-inden-1-amine derivatives as selective monoamine oxidase B inhibitors.来源期刊：Bioorganic & medicinal chemistry lettersDOI：10.1016/j.bmcl.2019.02.030Design, synthesis and biological evaluation of benzimidazole derivatives as novel human Pin1 inhibitors.来源期刊：Bioorganic & medicinal chemistry lettersDOI：10.1016/J.BMCL.2018.11.045Essential ingredients for rational drug design.来源期刊：Bioorganic & medicinal chemistry lettersDOI：10.1016/j.bmcl.2019.126674Peptides conjugated to 2-alkoxy-8-oxo-adenine as potential synthetic vaccines triggering TLR7.来源期刊：Bioorganic & medicinal chemistry lettersDOI：10.1016/j.bmcl.2019.03.048Novel M4 positive allosteric modulators derived from questioning the role and impact of a presumed intramolecular hydrogen-bonding motif in β-amino carboxamide-harboring ligands.来源期刊：Bioorganic & medicinal chemistry lettersDOI：10.1016/j.bmcl.2018.12.039Synthesis and in vitro activity of asymmetric indole-based bisamidine compounds against Gram-positive and Gram-negative pathogens.来源期刊：Bioorganic & medicinal chemistry lettersDOI：10.1016/j.bmcl.2019.126887Discovery of small molecule inhibitors of human uridine-cytidine kinase 2 by high-throughput screening.来源期刊：Bioorganic & medicinal chemistry lettersDOI：10.1016/j.bmcl.2019.08.010Biotinylated-spiperone ligands for quantum dot labeling of the dopamine D2 receptor in live cell cultures.来源期刊：Bioorganic & medicinal chemistry lettersDOI：10.1016/j.bmcl.2019.02.02419-Hydroxyeicosatetraenoic acid analogs: Antagonism of 20-hydroxyeicosatetraenoic acid-induced vascular sensitization and hypertension.来源期刊：Bioorganic & medicinal chemistry lettersDOI：10.1016/j.bmcl.2019.08.020Diarylcarbonates are a new class of deubiquitinating enzyme inhibitor.来源期刊：Bioorganic & medicinal chemistry lettersDOI：10.1016/j.bmcl.2018.11.055Structure-based design, synthesis and biological evaluation of a novel series of isoquinolone and pyrazolo[4,3-c]pyridine inhibitors of fascin 1 as potential anti-metastatic agents来源期刊：Bioorganic & Medicinal Chemistry LettersDOI：10.1016/j.bmcl.2019.01.035Structure-based design and discovery of potent and selective lysine-specific demethylase 1 (LSD1) inhibitors.来源期刊：Bioorganic & medicinal chemistry lettersDOI：10.1016/j.bmcl.2018.11.001Synthesis and antitumor activity of daunorubicin conjugates with of 3,4-methylendioxybenzaldehyde.来源期刊：Bioorganic & medicinal chemistry lettersDOI：10.1016/j.bmcl.2019.08.021Synthesis and antileishmanial evaluation of thiazole orange analogs.来源期刊：Bioorganic & medicinal chemistry lettersDOI：10.1016/j.bmcl.2019.126725Incorporation of privileged structures into 3-O-β-chacotriosyl ursolic acid can enhance inhibiting the entry of the H5N1 virus.来源期刊：Bioorganic & medicinal chemistry lettersDOI：10.1016/j.bmcl.2019.07.028Novel sulfonamides against Botrytis cinerea with no positive cross-resistance to commercial fungicides: Design, synthesis and SAR study.来源期刊：Bioorganic & medicinal chemistry lettersDOI：10.1016/j.bmcl.2019.126859Evaluation of quinoxaline compounds as ligands of a site adjacent to S2 (AS2) of cruzain.来源期刊：Bioorganic & medicinal chemistry lettersDOI：10.1016/j.bmcl.2019.06.046Upregulation of p53 through induction of MDM2 degradation: Amino acid prodrugs of anthraquinone analogs.来源期刊：Bioorganic & medicinal chemistry lettersDOI：10.1016/j.bmcl.2019.1267862,4,5-Tris(alkoxyaryl)imidazoline derivatives as potent scaffold for novel p53-MDM2 interaction inhibitors: Design, synthesis, and biological evaluation.来源期刊：Bioorganic & medicinal chemistry lettersDOI：10.1016/j.bmcl.2019.06.007Discovery and optimization of covalent Bcl-xL antagonists.来源期刊：Bioorganic & medicinal chemistry lettersDOI：10.1016/j.bmcl.2019.126682Microwave-assisted synthesis and in vitro stability of N-benzylamide non-steroidal anti-inflammatory drug conjugates for CNS delivery.来源期刊：Bioorganic & medicinal chemistry lettersDOI：10.1016/j.bmcl.2019.04.016Functional expression of a highly-reducing polyketide synthase of Emericella variecolor IFM42010, an asteltoxin-producing strain, resulted in production of two polyenoic β-ketolactones with opposite stereochemistry.来源期刊：Bioorganic & medicinal chemistry lettersDOI：10.1016/j.bmcl.2019.126686Chemically synthesized LYRM03 could inhibit the metastasis of human breast cancer MDA-MB-231 cells in vitro and in vivo.来源期刊：Bioorganic & medicinal chemistry lettersDOI：10.1016/j.bmcl.2019.05.027Synthesis, fungicidal activity and SAR of 3,4-dichloroisothiazole-based cycloalkylsulfonamides.来源期刊：Bioorganic & medicinal chemistry lettersDOI：10.1016/j.bmcl.2019.03.047Serendipitous discovery of aryl boronic acids as β-lactamase inhibitors.来源期刊：Bioorganic & medicinal chemistry lettersDOI：10.1016/j.bmcl.2019.126795Prodrugs of the cancer cell selective anti-cancer agent (Z)-2-(1H-indol-3-yl)-3-(isoquinolin-5-yl)acrylonitrile (A131) are orally efficacious in a mouse model of resistant colon cancer.来源期刊：Bioorganic & medicinal chemistry lettersDOI：10.1016/j.bmcl.2018.11.053Synthesis and biological evaluation of 3-amino-, 3-alkoxy- and 3-aryloxy-6-(hetero)arylpyridazines as potent antitumor agents.来源期刊：Bioorganic & medicinal chemistry lettersDOI：10.1016/j.bmcl.2018.12.050Identification of BR101549 as a lead candidate of non-TZD PPARγ agonist for the treatment of type 2 diabetes: Proof-of-concept evaluation and SAR.来源期刊：Bioorganic & medicinal chemistry lettersDOI：10.1016/j.bmcl.2018.12.043Discovery of a C-8 hydroxychromene as a potent degrader of estrogen receptor alpha with improved rat oral exposure over GDC-0927.来源期刊：Bioorganic & medicinal chemistry lettersDOI：10.1016/j.bmcl.2019.07.013Discovery of 1,8-disubstituted-[1,2,3]triazolo[4,5-c]quinoline derivatives as a new class of Hippo signaling pathway inhibitors.来源期刊：Bioorganic & medicinal chemistry lettersDOI：10.1016/j.bmcl.2019.08.001Further exploration of the structure-activity relationship of imidazoquinolines; identification of potent C7-substituted imidazoquinolines.来源期刊：Bioorganic & medicinal chemistry lettersDOI：10.1016/j.bmcl.2019.126788Structure-based design of guanosine analogue inhibitors targeting GTP cyclohydrolase IB towards a new class of antibiotics.来源期刊：Bioorganic & medicinal chemistry lettersDOI：10.1016/j.bmcl.2019.126818Synthesis and evaluation of thieno[3,2-d]pyrimidine derivatives as novel FMS inhibitors.来源期刊：Bioorganic & medicinal chemistry lettersDOI：10.1016/j.bmcl.2018.11.037Discovery of a novel 2,3-dimethylimidazo[1,2-a]pyrazine-6-carboxamide M4 positive allosteric modulator (PAM) chemotype.来源期刊：Bioorganic & medicinal chemistry lettersDOI：10.1016/j.bmcl.2019.126812SAR inspired by aldehyde oxidase (AO) metabolism: Discovery of novel, CNS penetrant tricyclic M4 PAMs.来源期刊：Bioorganic & medicinal chemistry lettersDOI：10.1016/j.bmcl.2019.06.032Design, synthesis and biological evaluation of mogrol derivatives as a novel class of AMPKα2β1γ1 activators.来源期刊：Bioorganic & medicinal chemistry lettersDOI：10.1016/j.bmcl.2019.126790Development of the binding molecules for the RNA higher-order structures based on the guanine-recognition by the G-clamp.来源期刊：Bioorganic & medicinal chemistry lettersDOI：10.1016/j.bmcl.2019.03.052Synthesis of 2-arylhydrazinylidene-3-oxo-4,4,4-trifluorobutanoic acids as new selective carboxylesterase inhibitors and radical scavengers.来源期刊：Bioorganic & medicinal chemistry lettersDOI：10.1016/j.bmcl.2019.126716Synthesis and biological evaluation of Vinpocetine derivatives.来源期刊：Bioorganic & medicinal chemistry lettersDOI：10.1016/J.BMCL.2019.05.052Facile synthesis of carbon-11-labeled sEH/PDE4 dual inhibitors as new potential PET agents for imaging of sEH/PDE4 enzymes in neuroinflammation.来源期刊：Bioorganic & medicinal chemistry lettersDOI：10.1016/j.bmcl.2019.04.036Targeting TRAIL.来源期刊：Bioorganic & medicinal chemistry lettersDOI：10.1016/j.bmcl.2019.07.053Synthesis and antitumor activity of bis(arylsulfonyl)dihydroimidazolinone derivatives.来源期刊：Bioorganic & medicinal chemistry lettersDOI：10.1016/j.bmcl.2019.126776The role of N-terminal heterocycles in hydrogen bonding to α-chymotrypsin.来源期刊：Bioorganic & medicinal chemistry lettersDOI：10.1016/j.bmcl.2018.12.032查看更多质量指标占比研究类文章占比 OA被引用占比撤稿占比出版后修正文章占比 99.67%9.49%-1.07%相关指数影响因子影响因子年发文量自引率Cite Score

预警情况

查看说明时间预警情况 2025年03月发布的2025版不在预警名单中2024年02月发布的2024版不在预警名单中2023年01月发布的2023版不在预警名单中2021年12月发布的2021版不在预警名单中2020年12月发布的2020版不在预警名单中*来源：中科院《国际期刊预警名单》

JCR分区

WOS分区等级：Q3区版本按学科分区

WOS期刊SCI分区

WOS期刊SCI分区是指SCI官方（Web of

Science）为每个学科内的期刊按照IF数值排

序，将期刊按照四等分的方法划分的Q1-Q4等级，Q1代表质量最高，即常说的1区期刊。

（2024-2025年最新版）CHEMISTRY, MEDICINALQ3

中科院分区

查看说明版本大类学科小类学科 Top期刊综述期刊 2025年3月最新升级版医学4区CHEMISTRY, ORGANIC

有机化学2区CHEMISTRY, MEDICINAL

药物化学4区否否2023年12月升级版医学4区CHEMISTRY, ORGANIC

有机化学2区CHEMISTRY, MEDICINAL

药物化学4区否否2022年12月旧的升级版医学4区CHEMISTRY, ORGANIC

有机化学3区CHEMISTRY, MEDICINAL

药物化学4区否否

最近发表